Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Impact of pre-hospital antibiotic therapy on mortality in invasive meningococcal disease: a propensity score study.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Viladrich PF.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1671-1676. doi: 10.1007/s10096-019-03599-8. Epub 2019 May 28.

PMID:
31140070
2.

Risk factors for surgical site infection after craniotomy: a prospective cohort study.

Jiménez-Martínez E, Cuervo G, Hornero A, Ciercoles P, Gabarrós A, Cabellos C, Pelegrin I, García-Somoza D, Adamuz J, Carratalà J, Pujol M.

Antimicrob Resist Infect Control. 2019 May 2;8:69. doi: 10.1186/s13756-019-0525-3. eCollection 2019.

3.

Invasive Meningococcal Disease: What We Should Know, Before It Comes Back.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Fernandez Viladrich P.

Open Forum Infect Dis. 2019 Feb 7;6(3):ofz059. doi: 10.1093/ofid/ofz059. eCollection 2019 Mar.

4.

Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains.

Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Díaz-Pollán B, Cabellos C, García-Lechuz JM, Lora-Tamayo J, Domingo P, Muñez E, Domingo D, González-Romo F, Lepe-Jiménez JA, Rodríguez-Lucas C, Gil A, Pelegrín I, Chaves F, Pomar V, Ramos A, Alarcón T, Pérez-Cecilia E.

J Hosp Infect. 2019 May;102(1):108-115. doi: 10.1016/j.jhin.2018.11.008. Epub 2018 Nov 16.

PMID:
30448277
5.

Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.

El Haj C, Murillo O, Ribera A, Lloberas N, Gómez-Junyent J, Tubau F, Fontova P, Cabellos C, Ariza J.

Int J Antimicrob Agents. 2018 Jun;51(6):854-861. doi: 10.1016/j.ijantimicag.2018.01.014. Epub 2018 Jan 31.

PMID:
29374577
6.

Invasive meningococcal disease: Impact of short course therapy. A DOOR/RADAR study.

Cabellos C, Pelegrín I, Benavent E, Gudiol F, Tubau F, Garcia-Somoza D, Verdaguer R, Ariza J, Fernandez-Viladrich P.

J Infect. 2017 Nov;75(5):420-425. doi: 10.1016/j.jinf.2017.08.009. Epub 2017 Aug 25.

PMID:
28847701
7.

Management of Ventriculoperitoneal Shunt Infections in Adults: Analysis of Risk Factors Associated With Treatment Failure.

Pelegrín I, Lora-Tamayo J, Gómez-Junyent J, Sabé N, García-Somoza D, Gabarrós A, Ariza J, Viladrich PF, Cabellos C.

Clin Infect Dis. 2017 Apr 15;64(8):989-997. doi: 10.1093/cid/cix005.

PMID:
28329191
8.

The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?

El Haj C, Murillo O, Ribera A, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.

Med Microbiol Immunol. 2017 Feb;206(1):31-39. doi: 10.1007/s00430-016-0479-5. Epub 2016 Sep 17.

PMID:
27639707
9.

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.

Nicolás D, Esteve A, Cuadros A, Campbell CNJ, Tural C, Podzamczer D, Murillas J, Homar F, Segura F, Force L, Vilaró J, Masabeu À, Garcia I, Mercadal J, Montoliu A, Ferrer E, Riera M, Cifuentes C, Ambrosioni J, Navarro G, Manzardo C, Clotet B, Gatell JM, Casabona J, Miró JM; PISCIS Cohort Study Investigators, Murillas J, Manzardo C, Masabeu A, Mercadal J, Cifuentes C, Dalmau D, Domingo P, Falcó V, Curran A, Agustí C, Montoliu A, Pérez I, Curto J, Gargoulas F, Gómez A, Rubia JC, Zamora L, Blanco JL, Garcia-Alcaide F, Martínez E, Mallolas J, Llibre JM, Sirera G, Romeu J, Jou A, Negredo E, Saumoy M, Imaz A, Bolao F, Cabellos C, Peña C, DiYacovo S, Van Den Eynde E, Sala M, Cervantes M, Amengual MJ, Navarro M, Segura V, Barrufet P, Molina J, Alvaro M, Payeras T, Gracia Mateo M, Fernández J.

Clin Infect Dis. 2016 Jun 15;62(12):1578-1585. doi: 10.1093/cid/ciw157. Epub 2016 Apr 28.

PMID:
27126346
10.

ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.

van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Sipahi OR, Brouwer MC; ESCMID Study Group for Infections of the Brain (ESGIB).

Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62. doi: 10.1016/j.cmi.2016.01.007. Epub 2016 Apr 7. No abstract available.

11.

Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.

Vivas M, Force E, El Haj C, Tubau F, Ariza J, Cabellos C.

J Microbiol Immunol Infect. 2017 Aug;50(4):435-439. doi: 10.1016/j.jmii.2015.07.014. Epub 2015 Sep 9.

12.

Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.

El Haj C, Murillo O, Ribera A, Vivas M, Garcia-Somoza D, Tubau F, Cabellos C, Cabo J, Ariza J.

Int J Antimicrob Agents. 2015 Aug;46(2):189-95. doi: 10.1016/j.ijantimicag.2015.04.004. Epub 2015 May 21.

PMID:
26051988
13.

Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.

Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos C.

Int J Antimicrob Agents. 2015 Jul;46(1):28-32. doi: 10.1016/j.ijantimicag.2015.01.014. Epub 2015 Mar 6.

PMID:
25813395
14.

Short communication: focal encephalitis related to viral escape and resistance emergence in cerebrospinal fluid in a patient on lopinavir/ritonavir monotherapy with plasma HIV-1 RNA suppression.

Imaz A, Cayuela N, Niubó J, Tiraboschi JM, Izquierdo C, Cabellos C, Podzamczer D.

AIDS Res Hum Retroviruses. 2014 Oct;30(10):984-7. doi: 10.1089/AID.2014.0014. Epub 2014 Sep 8.

15.

Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.

Cabellos C, Garrigós C, Taberner F, Force E, Pachón-Ibañez ME.

J Infect Chemother. 2014 Sep;20(9):563-8. doi: 10.1016/j.jiac.2014.05.008. Epub 2014 Jun 25.

PMID:
24973908
16.

Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.

Vivas M, Force E, Garrigós C, Tubau F, Platteel AC, Ariza J, Cabellos C.

J Antimicrob Chemother. 2014 Nov;69(11):3020-6. doi: 10.1093/jac/dku231. Epub 2014 Jun 23.

PMID:
24962033
17.

Listeria monocytogenes meningoencephalitis in adults: analysis of factors related to unfavourable outcome.

Pelegrín I, Moragas M, Suárez C, Ribera A, Verdaguer R, Martínez-Yelamos S, Rubio-Borrego F, Ariza J, Viladrich PF, Cabellos C.

Infection. 2014 Oct;42(5):817-27. doi: 10.1007/s15010-014-0636-y. Epub 2014 Jun 6.

PMID:
24902522
18.

A second look at Emmonsia infection can make the difference.

Pelegrín I, Alastruey-Izquierdo A, Ayats J, Cuenca-Estrella M, Cabellos C.

Transpl Infect Dis. 2014 Jun;16(3):519-20. doi: 10.1111/tid.12214. Epub 2014 May 5. No abstract available.

PMID:
24796631
19.

Primary lumbar epidural abscess without spondylodiscitis caused by Fusobacterium necrophorum diagnosed by 16S rRNA PCR.

Sanmillán JL, Pelegrín I, Rodríguez D, Ardanuy C, Cabellos C.

Anaerobe. 2013 Oct;23:45-7. doi: 10.1016/j.anaerobe.2013.06.014. Epub 2013 Jul 8.

PMID:
23845584
20.

Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Lora-Tamayo J, Verdaguer R, Tubau F, Cabellos C, Cabo J, Ariza J.

Antimicrob Agents Chemother. 2013 Jan;57(1):606-10. doi: 10.1128/AAC.01570-12. Epub 2012 Oct 22.

21.

RNAIII inhibiting peptide against foreign-body infection by methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Lora-Tamayo J, Vivas M, Tubau F, Cabellos C, Cabo J, Ariza J.

J Infect. 2012 Dec;65(6):586-8. doi: 10.1016/j.jinf.2012.09.012. Epub 2012 Oct 2. No abstract available.

PMID:
23041475
22.

Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Lora-Tamayo J, Verdaguer R, Tubau F, Cabellos C, Cabo J, Ariza J.

Antimicrob Agents Chemother. 2012 Jul;56(7):3806-11. doi: 10.1128/AAC.00127-12. Epub 2012 May 14.

23.

Arthritis related to systemic meningococcal disease: 34 years' experience.

Cabellos C, Nolla JM, Verdaguer R, Pelegrin I, Ribera A, Ariza J, Viladrich PF.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2661-6. Epub 2012 Apr 3.

PMID:
22476361
24.

Methicillin-resistant Staphylococcus aureus meningitis in adults: a multicenter study of 86 cases.

Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Gil A, García-Lechuz JM, Cabellos C, Chaves F, Domingo P, Ramos A, Pérez-Cecilia E, Domingo D.

Medicine (Baltimore). 2012 Jan;91(1):10-7. doi: 10.1097/MD.0b013e318243442b.

25.

Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Ariza J.

J Infect. 2011 Sep;63(3):229-35. doi: 10.1016/j.jinf.2011.07.001. Epub 2011 Jul 7.

PMID:
21763722
26.

Disseminated adiaspiromycosis: case report of a liver transplant patient with human immunodeficiency infection, and literature review.

Pelegrín I, Ayats J, Xiol X, Cuenca-Estrella M, Jucglà A, Boluda S, Fernàndez-Sabé N, Rafecas A, Gudiol F, Cabellos C.

Transpl Infect Dis. 2011 Oct;13(5):507-14. doi: 10.1111/j.1399-3062.2011.00611.x. Epub 2011 Feb 15. Review.

PMID:
21323828
27.

Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Garrigós C, Murillo O, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Ariza J.

Antimicrob Agents Chemother. 2010 Dec;54(12):5251-6. doi: 10.1128/AAC.00226-10. Epub 2010 Oct 4.

28.

Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.

Pachón-Ibáñez ME, Ribes S, Domínguez MA, Fernández R, Tubau F, Ariza J, Gudiol F, Cabellos C.

Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):89-95. doi: 10.1007/s10096-010-1058-0. Epub 2010 Sep 16.

PMID:
20844913
29.

In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.

Ribes S, Pachón-Ibáñez ME, Domínguez MA, Fernández R, Tubau F, Ariza J, Gudiol F, Cabellos C.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1361-7. doi: 10.1007/s10096-010-1007-y. Epub 2010 Aug 1.

30.

Herpes simplex encephalitis in older adults.

Riera-Mestre A, Requena A, Martínez-Yelamos S, Cabellos C, Fernández-Viladrich P.

J Am Geriatr Soc. 2010 Jan;58(1):201-2. doi: 10.1111/j.1532-5415.2009.02655.x. No abstract available.

PMID:
20122069
31.

Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.

Murillo O, Pachón ME, Euba G, Verdaguer R, Carreras M, Cabellos C, Cabo J, Gudiol F, Ariza J.

J Antimicrob Chemother. 2009 Nov;64(5):1062-6. doi: 10.1093/jac/dkp326. Epub 2009 Sep 10.

PMID:
19744977
32.

Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Murillo O, Garrigós C, Pachón ME, Euba G, Verdaguer R, Cabellos C, Cabo J, Gudiol F, Ariza J.

Antimicrob Agents Chemother. 2009 Oct;53(10):4252-7. doi: 10.1128/AAC.00208-09. Epub 2009 Jul 27.

33.

Fungal postoperative spondylodiscitis due to Scedosporium prolificans.

Garcia-Vidal C, Cabellos C, Ayats J, Font F, Ferran E, Fernandez-Viladrich P.

Spine J. 2009 Sep;9(9):e1-7. doi: 10.1016/j.spinee.2009.03.012. Epub 2009 May 17. Review.

PMID:
19447683
34.

Adult herpes simplex encephalitis: fifteen years' experience.

Riera-Mestre A, Gubieras L, Martínez-Yelamos S, Cabellos C, Fernández-Viladrich P.

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):143-7. doi: 10.1016/j.eimc.2008.05.006. Epub 2009 Feb 14.

PMID:
19306713
35.

Community-acquired bacterial meningitis in elderly patients: experience over 30 years.

Cabellos C, Verdaguer R, Olmo M, Fernández-Sabé N, Cisnal M, Ariza J, Gudiol F, Viladrich PF.

Medicine (Baltimore). 2009 Mar;88(2):115-9. doi: 10.1097/MD.0b013e31819d50ef.

36.

Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.

Force E, Taberner F, Cabellos C, Ribes S, Doménech A, Tubau F, Viladrich PF, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):807-11. doi: 10.1007/s10096-009-0711-y. Epub 2009 Feb 17.

PMID:
19221815
37.

High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.

Murillo O, Pachón ME, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Gudiol F, Ariza J.

J Infect. 2009 Mar;58(3):220-6. doi: 10.1016/j.jinf.2009.01.005. Epub 2009 Feb 12.

PMID:
19217166
38.

Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.

Murillo O, Domenech A, Euba G, Verdaguer R, Tubau F, Cabo J, Cabellos C, Gudiol F, Ariza J.

J Infect. 2008 Sep;57(3):229-35. doi: 10.1016/j.jinf.2008.07.003. Epub 2008 Aug 19.

PMID:
18715649
39.

Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection.

Murillo O, Pachón ME, Euba G, Verdaguer R, Tubau F, Cabellos C, Cabo J, Gudiol F, Ariza J.

Antimicrob Agents Chemother. 2008 Oct;52(10):3681-6. doi: 10.1128/AAC.00458-08. Epub 2008 Aug 1.

40.

Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis.

Force E, Taberner F, Cabellos C, Ribes S, Domenech A, Tubau F, Viladrich PF, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):685-90. doi: 10.1007/s10096-008-0492-8. Epub 2008 Apr 2.

PMID:
18386085
41.

Paradoxical reaction of multiple cerebral tuberculomas.

Garcia-Vidal C, Cabellos C.

Mayo Clin Proc. 2008 Mar;83(3):264. No abstract available.

PMID:
18315989
42.

Contribution of capsular and clonal types and beta-lactam resistance to the severity of experimental pneumococcal meningitis.

Ribes S, Taberner F, Cabellos C, Tubau F, Ardanuy C, Gerber J, Liñares J, Nau R, Gudiol F.

Microbes Infect. 2008 Feb;10(2):129-34. doi: 10.1016/j.micinf.2007.10.014. Epub 2007 Nov 4.

PMID:
18248756
43.

Community-acquired bacterial meningitis in cirrhotic patients.

Cabellos C, Viladrich PF, Ariza J, Maiques JM, Verdaguer R, Gudiol F.

Clin Microbiol Infect. 2008 Jan;14(1):35-40. Epub 2007 Nov 13.

44.

Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa.

Maiques JM, Doménech A, Cabellos C, Fernández A, Ribes S, Tubau F, Gudiol F, Viladrich PF.

Microbes Infect. 2007 Apr;9(4):435-41. Epub 2007 Jan 12.

PMID:
17350305
45.

Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.

Murillo O, Doménech A, Garcia A, Tubau F, Cabellos C, Gudiol F, Ariza J.

Antimicrob Agents Chemother. 2006 Dec;50(12):4011-7. Epub 2006 Oct 2.

46.

Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.

Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Viladrich PF, Gudiol F.

J Antimicrob Chemother. 2006 May;57(5):931-6. Epub 2006 Feb 28.

PMID:
16507562
47.

Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.

Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Fernández Viladrich P, Gudiol F.

J Antimicrob Chemother. 2005 Nov;56(5):979-82. Epub 2005 Sep 20.

PMID:
16174686
48.

Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.

Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.

J Antimicrob Chemother. 2005 Oct;56(4):709-16. Epub 2005 Aug 24.

PMID:
16120625
49.

A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.

Domenech A, Ribes S, Cabellos C, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.

Microb Drug Resist. 2004 Winter;10(4):346-53.

PMID:
15650381
50.

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Borraz C, Gudiol F.

J Antimicrob Chemother. 2004 Dec;54(6):1085-91. Epub 2004 Nov 16.

PMID:
15546972

Supplemental Content

Loading ...
Support Center